HUMACAO, PR and NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery ...
Study comparing BioStem’s proprietary amnion chorion allograft versus the standard of care aims to demonstrate superior outcomes, further validating its clinical efficacy to support market expansion ...
The mission of Pratt Institute’s Human Research Subjects Committee / Institutional Review Board (IRB) is to ensure quality research involving human subjects conducted under the auspices of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback